Down2Earth Capital-backed Accuramed Acquires BeMedico to Expand Interventional Medicine Portfolio

Accuramed, a company specializing in interventional medicine backed by Down2Earth Capital, has completed the acquisition of BeMedico, a Belgian medical supplies firm based in Herzele. This strategic move enhances Accuramed’s portfolio by incorporating a broad range of consumables and devices that serve multiple medical specialties.

The acquisition, announced on April 22, 2026, marks a significant step for Accuramed in expanding its product offerings. BeMedico supports healthcare professionals in fields such as orthopaedics, traumatology, dermatology, plastic surgery, gynaecology, maxillofacial surgery, oncology, rehabilitation, dentistry, and urology. Its product range includes implants, braces, orthobiologicals, medical and aesthetic lasers, cooling solutions, exoskeletons, and shockwave therapy systems.

Accuramed aims to leverage BeMedico’s complementary portfolio to cross-sell products to existing customers and enter new specialty markets. The acquisition also allows for operational synergies, including consolidated procurement, streamlined supply chains, and enhanced inventory management. These efficiencies are expected to improve service delivery and customer support through combined expertise and consulting capabilities.

BeMedico, headquartered in Herzele, Belgium, has built a reputation for supporting diverse medical disciplines with innovative consumables and devices. Accuramed’s acquisition strengthens its position in the interventional medicine sector by broadening its specialty coverage and product range, particularly in the Belgian market.

Industry consolidation in healthcare and medical devices is accelerating, and this acquisition positions Accuramed to better compete against peers by offering a more comprehensive product suite. Competitors may respond with similar acquisitions or increased investment in innovation and customer service.

Integration challenges include aligning diverse product lines and sales strategies, merging operational systems, and maintaining strong customer relationships during the transition. However, Accuramed’s focus on combining product development efforts and consulting expertise aims to mitigate these risks.

Looking ahead, Accuramed plans to integrate BeMedico’s offerings fully and capitalize on cross-selling opportunities to drive growth. The acquisition underscores Accuramed’s commitment to expanding its footprint in interventional medicine and enhancing value for healthcare providers and patients alike.